查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1197263

工業微生物學測試市場 - 增長、趨勢、COVID-19 影響和預測 (2023-2028)

Industrial Microbiology Market - Growth, Trends, and Forecasts (2023 - 2028)
出版日期: | 出版商: Mordor Intelligence | 英文 111 Pages | 商品交期: 2-3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

在預測期內（2023 年至 2028 年），工業微生物檢測市場預計將以 6.9% 的複合年增長率增長。

COVID-19 大流行的出現對全球經濟產生了重大影響，不僅影響醫療保健行業，也影響其他行業。 世界各國政府為遏制 COVID-19 的傳播而實施的限制擾亂了製藥和生物技術供應鏈之外的製造、樣品測試、研發活動等服務，並對工業微生物學市場產生了影響。 例如，根據 2021 年 10 月發表的題為“COVID-19 對南亞農業生產和分配的影響”的研究，印度、孟加拉國和巴基斯坦發現 COVID-19 在收穫季節出現，導致活動據說這些國家的農產品生產和流通等都受到了很大影響。

然而，根據 Elsevier 公共衛生緊急情況合集於 2021 年 12 月在大流行之前發表的一篇題為“冠狀病毒大流行期間膳食補充劑和營養保健品市場增長——對消費者和監管的影響”的文章，觀察到以下情況。 與 2019 年同期相比，2019 年營養補充劑銷售額增長 5%，達到 3.45 億美元，在 2020 年 4 月 5 日第一波大流行之前的六週內，銷售額增長了 44%（4.35 億美元）。 此外，根據同一消息來源，2020 年 3 月美國複合維生素的銷售額增長了 51.2%，在此期間銷售了近 1.2 億種維生素和補充劑。 此外，2020 年 3 月維生素在英國的銷售額增長了 63%，在法國的銷售額增長了約 40-60%。 這樣，用於維持和改善免疫系統的多種維生素和益生菌的銷量在每個國家都在增加，預計這將對調查市場產生重大影響。 同樣，COVID-19 也導致了全球各行業微生物檢測的新規範。 由於 COVID-19 病例數量下降，所研究的市場有望在研究預測期內恢復其全部潛力。

營養保健品和發酵食品在世界範圍內越來越受歡迎，並在食品安全方面發揮著重要作用。 因此，隨著世界對它們的需求增加，對高級檢測以保持產品質量和完整性的需求也在增加。 因此，全球對工業微生物學產品的需求正在增加，預計將成為本研究預測期內工業微生物學市場增長的主要因素。 例如，根據印度政府食品加工工業部的數據，2020 年印度的保健食品市場規模為 40 億美元。 此外，根據同一消息來源，該國的膳食補充劑市場預計從 2019 年到 2024 年將增長 7%。 印度人開始相信增強免疫力的補充劑，消費者和市場行為的購買模式也發生了重大轉變。 此外，美國在臨床營養方面取得了許多進步。 例如，2021 年 11 月，雅培宣布推出 Similac 360 Total Care，這是美國首款也是唯一一款將五種母乳低聚醣 (HMO) 混合在一起的嬰兒配方奶粉，此前僅在母乳中才能發現。 本產品提供營養以支持寶寶的全面健康和發育，包括免疫系統、消化系統和大腦。 維生素膠囊和咀嚼片等膳食補充劑在全球範圍內的需求不斷增加，以治療各種疾病，尤其是兒童和老年人，並且對微生物檢測以確保產品質量的需求不斷增長。預計工業微生物檢測市場將在預測期預計會增加。

預計會對工業微生物檢測市場產生積極影響的其他主要因素包括增加工業微生物檢測的研發支出、改進或加強工業微生物檢測程序、推出新的和先進的產品。 例如，2022 年 6 月，STEMart 推出了針對無菌、無熱原產品的全面微生物和無菌測試服務。 此外，2021 年 12 月，在印度，AKTA Nutrition 與 Sundyota Numandis Group 合作推出了一系列採用優質原材料的營養補充劑產品。 產品包括 Bye-Bye Stress（促進放鬆和睡眠）、Good Immunity（促進身體抵抗感染的自然能力）和 Beet Strong（增加甜菜的益處以促進整體健康）。 同樣，2020 年 7 月，Neogen Co., Ltd. 推出了 Soleris Next Generation (NG)，這是一種先進的測試系統，與傳統測試方法相比，它可以在很短的時間內自動檢測微生物。 我們快速檢測多種微生物，並提供安全、優質的食品和化妝品。 因此，預計產品發布的增加和企業活動的增加將增加對微生物檢測產品的需求，從而推動預測期內的市場增長。

但是，預計在預測期內，食品來源中使用轉基因生物的爭議和產品召回的增加等因素將抑制工業微生物檢測市場的增長。

工業微生物檢測市場趨勢

在預測期內，製藥和生物技術行業預計將佔據工業微生物檢測市場的很大份額

由於研發活動的增加、救生藥物的生產和各種適應症的治療，特別是抗生素和抗菌劑的生產等因素，預計製藥和生物技術行業在預測期內將實現市場增長。預計將錄得顯著增長 隨著全球對藥物和療法的需求不斷增加，微生物學在製藥和生物技術行業中的作用也在增加，這有望推動研究學科領域的發展。

全球製藥和生物技術公司不斷增加的研發支出預計將成為所研究市場的製藥和生物技術行業在研究預測期內增長的主要驅動力。 例如，美國國會預算辦公室公佈的數據證實，2021 年 6 月，製藥行業將在全球範圍內投入近 2000 億美元用於研發，而 2019 年為 8300 萬美元。 此外，Becton, Dickinson, and Company 在 2021 財年的研發活動支出為 13.39 億美元，而 2020 財年為 10.96 億美元。 同樣，Thermo Fisher Scientific Inc. 在 2021 財年的研發活動支出為 14.06 億美元，而 2020 財年為 11.81 億美元。 因此，隨著研發支出的增加，預計製藥和生物技術行業將在預測期內佔據所研究市場的很大份額。

此外，2020 年 7 月，20 多家領先的生物製藥公司聯合成立了抗菌素耐藥性 (AMR) 行動基金。 這一開創性的合作夥伴關係旨在到 2030 年為患者帶來 2-4 種新型抗生素，投資近 10 億美元幫助對抗最具耐藥性的細菌和致命感染。目的是資助針對創新型新型抗生素的臨床研究 預計這將有助於預測期內市場的增長。

因此，由於上述因素，預計在本研究的預測期內，製藥和生物技術行業將佔據工業微生物檢測市場的主要份額。

北美主導市場，預計在預測期內也會如此

北美的製藥、生物技術和食品行業對新產品研發進行了大量投資，該地區對營養補充劑和發酵產品的需求不斷增長，並且該地區的產品發布預計將佔據主導地位由於在預測期內的增加，市場份額很大 例如，根據加拿大統計局 2021 年 5 月的報告，2019 年加拿大製藥業在研發上的支出在 15 億美元至 40 億美元之間，其中 20 億美元和 1.5 億美元用於國內和國際外包研發業務。 因此，由於上述因素，預計北美地區在所研究市場的預測期內將佔據很大份額。

在北美地區，大型製藥和食品公司的存在，以及在該國開設新測試設施和該地區主要市場參與者推出新產品以及擴張，已經導致 預計將佔據被研究市場的很大份額。 例如，2022 年 6 月，SGS 在亞利桑那州鳳凰城開設了生物安全二級微生物實驗室。 此次發布將使該公司能夠為在該地區運營的公司提供更多本地化和專業化的測試。 此外，2021 年 5 月，Becton、Dickinson 和 Company 在美國推出了尿液培養應用程序，用於 BD Kiestra 實驗室自動化孵化和成像系統。 因此，預計在該地區推出更多產品將促進市場增長。

此外，製藥和生物技術公司越來越多地採用合作夥伴關係和協議等各種商業戰略，預計也將在預測期內推動市場增長。 例如，2020 年 7 月，Baxter International, Inc. 與 VIPUN Medical 達成協議，將 VIPUN 胃監測系統商業化。 通過使用專為測量胃動力而設計的智能腸內餵養管，重症監護病房 (ICU) 等臨床醫生可以更準確地識別腸內餵養阻力並為營養治療決策提供信息。您可以做到。

因此，由於上述因素，預測期內該地區的工業微生物檢測市場有望顯著增長。

工業微生物檢測市場競爭者分析

工業微生物檢測市場競爭相當激烈，因為在不同的地理位置存在多家公司，這些公司能夠通過提供其所在地區的最新產品在國內和國際上展開競爭。我們支持不同的行業在國際水平上發展. 該市場的主要參與者包括 bioMerieux SA、Bio-Rad Laboratories、Thermo Fisher Scientific Inc.、Becton、Dickinson and Company、Qiagen NV 等。

其他好處

  • Excel 格式的市場預測 (ME) 表
  • 三個月的分析師支持

內容

第1章介紹

  • 研究假設和市場定義
  • 調查範圍

第2章研究方法論

第 3 章執行摘要

第4章市場動態

  • 市場概覽
  • 市場驅動力
    • 越來越偏愛膳食補充劑和其他發酵產品
    • 研發費用增加，技術創新取得進展
    • 人們對食品安全的擔憂加劇
  • 市場製約因素
    • 關於在食物來源中使用轉基因生物的爭議
    • 產品召回率增加
  • 五力分析分析
    • 新進入者的威脅
    • 買方/消費者議價能力
    • 供應商的議價能力
    • 替代品的威脅
    • 競爭公司之間的敵對關係

第 5 章市場細分（基於價值的市場規模：100 萬美元）

  • 按產品類型
    • 設備/系統
    • 消耗品
    • 試劑
  • 按應用領域
    • 食品和飲料行業
    • 製藥/生物技術
    • 農業
    • 環保行業
    • 化妝品和個人護理行業
    • 其他應用領域
  • 按地區
    • 北美
      • 美國
      • 加拿大
      • 墨西哥
    • 歐洲
      • 德國
      • 英國
      • 法國
      • 意大利
      • 西班牙
      • 其他歐洲地區
    • 亞太地區
      • 中國
      • 日本
      • 印度
      • 澳大利亞
      • 韓國
      • 其他亞太地區
    • 中東
      • 海灣合作委員會
      • 南非
      • 其他中東地區
    • 南美洲
      • 巴西
      • 阿根廷
      • 其他南美洲

第6章競爭格局

  • 公司簡介
    • 3M Company
    • Agilent Technologies
    • Becton Dickinson and Company
    • BioMerieux SA
    • Bio-Rad Laboratories Inc.
    • Danaher Corporation
    • Eppendorf AG
    • Qiagen NV
    • Merck KGaA
    • Thermo Fisher Scientific Inc.
    • Sartorius AG
    • Asiagel Corporation

第7章 市場機會與今後動向

簡介目錄
Product Code: 62779

The industrial microbiology market is expected to register a CAGR of 6.9% during the forecast period (2023 - 2028).

The emergence of the COVID-19 pandemic had a significant impact on the global economy, which not only impacted the healthcare sector but other sectors too. The restrictions imposed by respective governments across the world to curb the spread of infections led to disruption in services like manufacturing, sample testing, research, and development activities other than COVID-19, pharmaceutical and biotechnology supply chain, which had their impact on the industrial microbiology market. For instance, according to the research study published in October 2021, titled "Impact of COVID-19 on agricultural production and distribution in South Asia", in India, Bangladesh, and Pakistan, the agriculture sector was severely impacted as the COVID-19 emerged in these regions during harvest time, and thus, production, distribution and other activities were impacted for agriculture products in these countries.

However, according to an article published by the Elsevier Public Health Emergency Collection, in December 2021, titled "Dietary supplements and nutraceuticals market growth during the coronavirus pandemic - Implications for consumers and regulatory oversight", it has been observed that before the pandemic, the dietary supplement sales in the United States increased by 5% to USD 345 million in 2019 and there was a 44% (USD 435 million) rise in sales in the six weeks before April 5th, 2020, during the first wave of the pandemic as compared to the same period in 2019. In addition, as per the same source, multivitamin sales increased by 51.2% in March 2020 in the United States, and nearly 120 million units of vitamins and supplements were sold during that period. Furthermore, vitamin sales increased by 63% in the United Kingdom, and in France, sales grew by approximately 40-60% in March 2020. Thus, the increased sales of multivitamins, probiotics, and other products in the countries to maintain and improve the immune system is expected to significantly impact the studied market. Likewise, COVID-19 also led to new norms for microbial testing in various industries worldwide. With decreasing COVID-19 cases, the studied market is expected to regain its full potential during the forecast period of the study.

Nutraceutical and fermented food products are gaining traction worldwide and playing an important role in food security; thus, with an increase in their global demand, the need for advanced testing is also increasing to maintain the quality and integrity of the products. Hence, the demand for products used in industrial microbiology is increasing worldwide, which is expected to be a major growth factor for the growth of the industrial microbiology market during the forecast period of the study. For instance, according to the Ministry of Food Processing Industries of the Government of India, the nutraceuticals market was USD 4 billion in India in 2020. Further, as to the same source, the nutraceutical market is expected to grow by 7% from 2019 to 2024 in the country. The Indian population has started to believe in immunity-boosting supplements, which has significantly changed buying patterns of consumer behavior and market behavior. Additionally, the United States saw many developments concerning clinical nutrition. For instance, in November 2021, Abbott launched Similac 360 Total Care, the first and only infant formula in the United States with a blend of five different Human Milk Oligosaccharides (HMOs), previously only found together in breast milk. The product provides nutrition to support a baby's complete health and development, including the immune system, digestive system, and brain. With the increasing demand for vitamin capsules, chewable tablets, and other nutraceutical products for treating various conditions in populations, especially pediatric and geriatric populations, all over the world is expected to increase the demand for microbiology testing to assuring the quality of the products and thus, the industrial microbiology market is expected to grow over the forecast period.

Other major factors that are expected to positively impact the industrial microbiology market include increasing research and development expenditure in industrial microbiology and the launch of new and advanced products that can improve or enhance industrial microbiology procedures. For instance, in June 2022, STEMart launched comprehensive microbiological and sterility testing services for sterile, non-pyrogenic products. Additionally, in December 2021, in India, AKTA Nutrition partnered with Sundyota Numandis Group to launch a nutraceutical product line utilizing quality ingredients. The product offerings include Bye-Bye Stress (which promotes relaxation and sleep), Good Immunity (which promotes the body's natural capacity to fight against infections), and Beet Strong (which promotes overall well-being with added benefits of beetroot). Similarly, in July 2020, Neogen Corporation launched an advanced test system, Soleris Next Generation (NG), which automatically detects microorganisms in a fraction of the time of traditional testing methods. The system rapidly detects a wide variety of microorganisms to provide safe and high-quality food and cosmetic products. Thus, increasing product launches and rising company activities are expected to increase the demand for microbiology testing products which is anticipated to fuel the market growth over the forecast period.

However, factors such as conflicts regarding the usage of genetically modified organisms in food sources and increasing product recalls are expected to restrain the growth of the industrial microbiology market during the forecast period.

Industrial Microbiology Market Trends

Pharmaceutical and Biotechnology Industry Segment is Expected to Have a Significant Share in the Industrial Microbiology Market During Forecast Period

The pharmaceutical and biotechnology industry segment is expected to register significant growth in the market over the forecast period owing to the factors such as increasing research and development activities, and the manufacturing of life-saving drugs and therapies for various indications, especially in the manufacturing of antibiotics or antimicrobials. With the increasing demand for drugs and therapies around the world, the role of microbiology is also expected to increase in the pharmaceutical and biotechnology industry, which is expected to fuel growth in the studied segment.

The increasing research and development expenditure by the pharmaceutical and biotechnology companies around the world is expected to be the major driving factor for the growth in the pharmaceutical and biotechnology industry in the studied market over the forecast period of the study. For instance, according to the data published by the Congressional Budget Office, in June 2021, it has been observed that pharmaceutical industries have spent nearly USD 200 billion on research and development globally compared to USD 83 million in 2019. Additionally, Becton, Dickinson, and Company spent USD 1,339 million on its research and development activities in FY2021 compared to USD 1,096 million in FY2020. Similarly, Thermo Fisher Scientific Inc. spent USD 1,406 million on its research and development activities in FY2021 compared to USD 1,181 million in FY2020. Thus, with the increasing research and development expenditure, the pharmaceutical and biotechnology industry is expected to hold a significant share in the studied market over the forecast period.

Furthermore, in July 2020, over 20 leading biopharmaceutical companies joined forces to form the Antimicrobial Resistance (AMR) Action Fund, which is a ground-breaking partnership that aims to bring 2 to 4 new antibiotics to patients by 2030, with an investment of about USD 1 billion to fund and support clinical research of innovative new antibiotics that target the most resistant bacteria and fatal infections. This is expected to contribute to the growth of the market over the forecast period.

Therefore, owing to the above-mentioned factors, the pharmaceutical and biotechnology industry is expected to hold a major share in the industrial microbiology market over the forecast period of the study.

North America Dominates the Market and Expects to do Same in the Forecast Period

North America is expected to dominate the market with a significant share over the forecast period owing to a significant investment by the pharmaceutical, biotechnology, and food industry in the research and development of new products, along with growing demand for nutraceuticals and fermented products in the region and increasing product launches in the region. For instance, according to the May 2021 report of Statistics Canada, between USD 1.5 and USD 4.0 billion was spent on research and development by the Canadian pharmaceutical sector in 2019, of which USD 2 billion was spent on in-house research and USD 950 million spent on outsourcing research and development work, both domestically and outside Canada. Thus, due to these mentioned factors, the North American region is expected to hold a significant share in the studied market over the forecast period of the study.

In the North American region, the United States is expected to occupy a major share in the studied market due to the factors such as the presence of large-scale pharmaceutical and food companies, and the launch of new products along with the opening and expansion of new testing facilities in the country by key market players in the region. For instance, in June 2022, SGS launched a Biosafety Level-2 microbiology lab in Phoenix, Arizona. With this launch, the company can offer more localized specialist testing for companies operating in the region. Additionally, in May 2021, Becton, Dickinson, and Company launched Urine Culture Application for use with the BD Kiestra lab automation incubation and imaging system in the United States. Thus, increasing launches in the region are expected to boost the market growth.

Furthermore, the rising adoption of various business strategies such as partnerships and agreements by the pharmaceutical and biotechnology companies are also expected to increase the market growth over the forecast period. For instance, in July 2020, Baxter International Inc. signed an agreement with VIPUN Medical to commercialize the VIPUN Gastric Monitoring System. Using a smart enteral feeding tube designed to measure stomach motility, clinicians in the intensive care unit (ICU) and other settings can more accurately identify enteral feeding resistance and make decisions about nutrition therapy.

Hence, owing to the above-mentioned factors, the industrial microbiology market is expected to grow significantly over the forecast period in the region.

Industrial Microbiology Market Competitor Analysis

There are several companies in the industrial microbiology market across different geographical locations, which is why the market is fairly competitive, and these companies support different industries to grow at the domestic and international levels by offering the latest products in the area. Some of the major players in this market include bioMerieux SA, Bio-Rad Laboratories, Thermo Fisher Scientific Inc., Becton, Dickinson and Company, and Qiagen NV, among others.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Growing Preference for Nutraceuticals and Other Fermented Products
    • 4.2.2 Increasing Research and Development Expenditure and Increasing Innovation
    • 4.2.3 Rising Concern for Food Safety
  • 4.3 Market Restraints
    • 4.3.1 Conflicts Regarding Usage of Genetically Modified Organisms in Food Sources
    • 4.3.2 Increasing Product Recalls
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION (Market Size by Value- USD Million)

  • 5.1 By Product Type
    • 5.1.1 Equipment and Systems
    • 5.1.2 Consumables
    • 5.1.3 Reagents
  • 5.2 By Application Area
    • 5.2.1 Food and Beverage Industry
    • 5.2.2 Pharmaceutical and Biotechnology Industry
    • 5.2.3 Agricultural Industry
    • 5.2.4 Environmental Industry
    • 5.2.5 Cosmetic or Personal Care Industry
    • 5.2.6 Other Application Areas
  • 5.3 Geography
    • 5.3.1 North America
      • 5.3.1.1 United States
      • 5.3.1.2 Canada
      • 5.3.1.3 Mexico
    • 5.3.2 Europe
      • 5.3.2.1 Germany
      • 5.3.2.2 United Kingdom
      • 5.3.2.3 France
      • 5.3.2.4 Italy
      • 5.3.2.5 Spain
      • 5.3.2.6 Rest of Europe
    • 5.3.3 Asia-Pacific
      • 5.3.3.1 China
      • 5.3.3.2 Japan
      • 5.3.3.3 India
      • 5.3.3.4 Australia
      • 5.3.3.5 South Korea
      • 5.3.3.6 Rest of Asia-Pacific
    • 5.3.4 Middle-East
      • 5.3.4.1 GCC
      • 5.3.4.2 South Africa
      • 5.3.4.3 Rest of Middle-East
    • 5.3.5 South America
      • 5.3.5.1 Brazil
      • 5.3.5.2 Argentina
      • 5.3.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 3M Company
    • 6.1.2 Agilent Technologies
    • 6.1.3 Becton Dickinson and Company
    • 6.1.4 BioMerieux SA
    • 6.1.5 Bio-Rad Laboratories Inc.
    • 6.1.6 Danaher Corporation
    • 6.1.7 Eppendorf AG
    • 6.1.8 Qiagen NV
    • 6.1.9 Merck KGaA
    • 6.1.10 Thermo Fisher Scientific Inc.
    • 6.1.11 Sartorius AG
    • 6.1.12 Asiagel Corporation

7 MARKET OPPORTUNITIES AND FUTURE TRENDS